Senior management from Extract Technology were invited along with other manufacturers and industry representatives to attend the grand opening of Penn Pharmaceuticals new £14 million state-of-the art contained manufacturing facility in Tredegar, South Wales.
Richard Yarwood CEO of Penn Pharmaceuticals who has over 30 years of experience in providing integrated drug development, clinical trials supply and manufacturing services to the international healthcare industry described the new facility during his welcome speech as “World Class” .
Extract have been working closely with Penn Pharmaceutical over many years, but most recently supplying innovative containment systems for use within the new purpose built facility, which delivers extremely specified “contained manufacturing processes”
Extract Technology General Manager, Alan Wainwright commented; “It was great to be part of the grand opening and it has been our privilege and pleasure to support Penn Pharmaceuticals in achieving their goal.
Following the expansion, the facility is now operating ahead of schedule, developing and manufacturing a growing range of products, meeting the highest international quality standards.